GRP75 antibody

Synonyms:CSA antibody, GRP 75 antibody, GRP75 antibody, Heat shock 70 kDa protein 9 antibody, HSPA9 antibody, HSPA9B antibody, Mortalin antibody, MOT antibody, mot 2 antibody, MOT2 antibody, MTHSP75 antibody, PBP74 antibody, Peptide binding protein 74 antibody
Catalogue No.:FNab03661Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, WB, IHC, IF, FC, IP
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
GRP75 antibody
Catalogue No.
FNab03661
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
heat shock 70kDa protein 9(mortalin)
Alternative Names
CSA antibody, GRP 75 antibody, GRP75 antibody, Heat shock 70 kDa protein 9 antibody, HSPA9 antibody, HSPA9B antibody, Mortalin antibody, MOT antibody, mot 2 antibody, MOT2 antibody, MTHSP75 antibody, PBP74 antibody, Peptide binding protein 74 antibody
UniProt ID
P38646
Observed MW
74 kDa
Application
Tested Applications
ELISA, WB, IHC, IF, FC, IP
Recommended dilution
WB: 1:1000-1:4000; IP: 1:1000-1:4000; IHC: 1:20-1:200; IF: 1:10-1:100
Validated Images
NIH/3T3 cells were subjected to SDS PAGE followed by western blot with FNab03661(GRP75 antibody) at dilution of 1:2000
IP Result of anti-GRP75 (IP:FNab03661, 4ug; Detection:FNab03661 1:2000) with mouse brain tissue lysate 3680ug.
Immunohistochemistry of paraffin-embedded human breast cancer using FNab03661(GRP75 antibody) at dilution of 1:100
Immunofluorescent analysis of HepG2 cells using FNab03661 (GRP75 antibody) at dilution of 1:25 and Rhodamine-Goat anti-Rabbit IgG
Background
GRP75(also known as mortalin, HSPA9 or mt-Hsp70) is a constitutively expressed member of the HSPA(HSP70) family of heat-shock proteins. It is located in the mitochondrial matrix and anti-GRP75 is commonly used as the marker for mitochondria. It has been reported that GRP75 is enriched in cancer cells and contributes to carcinogenesis. In addition, decreased expression level of GRP75 has been found in neurodegenerative disorders like Parkinson’s disease.